➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKinsey
AstraZeneca
Baxter
McKesson

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

Cilostazol - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for cilostazol and what is the scope of freedom to operate?

Cilostazol is the generic ingredient in two branded drugs marketed by Actavis Elizabeth, Apotex Inc, Casi Pharms Inc, Chartwell Rx, Epic Pharma Llc, Hikma, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Nostrum Labs Inc, Pliva Hrvatska Doo, Slate, Teva, and Otsuka, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cilostazol. Eight suppliers are listed for this compound.

Drug Prices for cilostazol

See drug prices for cilostazol

Drug Sales Revenue Trends for cilostazol

See drug sales revenues for cilostazol

Recent Clinical Trials for cilostazol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sadat City UniversityPhase 1/Phase 2
Mayo ClinicPhase 1/Phase 2
Novartis PharmaceuticalsN/A

See all cilostazol clinical trials

Pharmacology for cilostazol

US Patents and Regulatory Information for cilostazol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka PLETAL cilostazol TABLET;ORAL 020863-002 Jan 15, 1999 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Chartwell Rx CILOSTAZOL cilostazol TABLET;ORAL 077831-001 Sep 24, 2012 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Pliva Hrvatska Doo CILOSTAZOL cilostazol TABLET;ORAL 077898-002 Oct 29, 2007 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Casi Pharms Inc CILOSTAZOL cilostazol TABLET;ORAL 077021-001 Nov 23, 2004 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKinsey
AstraZeneca
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.